
Neomente is an AI-powered Clinical Decision Support System (CDSS) that revolutionizes the diagnosis and treatment of mental disorders by combining genetic biomarkers, clinical data, and blood analysis in a single platform. It enables mental health professionals to provide personalized, precise treatments from the first attempt, addressing the high failure rate of conventional treatments. The platform integrates genetic and metabolic biomarker analysis, complete clinical history, and AI-assisted recommendations to optimize therapeutic decisions and improve adherence to international mental health protocols. Neomente is conducting clinical trials and has presented results at international congresses, positioning itself as a disruptive innovator in precision psychiatry with a comprehensive patient data approach and telemedicine integration.

Neomente is an AI-powered Clinical Decision Support System (CDSS) that revolutionizes the diagnosis and treatment of mental disorders by combining genetic biomarkers, clinical data, and blood analysis in a single platform. It enables mental health professionals to provide personalized, precise treatments from the first attempt, addressing the high failure rate of conventional treatments. The platform integrates genetic and metabolic biomarker analysis, complete clinical history, and AI-assisted recommendations to optimize therapeutic decisions and improve adherence to international mental health protocols. Neomente is conducting clinical trials and has presented results at international congresses, positioning itself as a disruptive innovator in precision psychiatry with a comprehensive patient data approach and telemedicine integration.